365 related articles for article (PubMed ID: 22492740)
1. The CFTR and ENaC debate: how important is ENaC in CF lung disease?
Collawn JF; Lazrak A; Bebok Z; Matalon S
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1141-6. PubMed ID: 22492740
[TBL] [Abstract][Full Text] [Related]
2. New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Giorgetti M; Klymiuk N; Bähr A; Hemmerling M; Jinton L; Tarran R; Malmgren A; Åstrand A; Hansson GC; Ermund A
Eur J Pharmacol; 2021 Aug; 904():174123. PubMed ID: 33974881
[TBL] [Abstract][Full Text] [Related]
3. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
[TBL] [Abstract][Full Text] [Related]
4. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
5. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
Gianotti A; Melani R; Caci E; Sondo E; Ravazzolo R; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628
[TBL] [Abstract][Full Text] [Related]
6. Loss of Cftr function exacerbates the phenotype of Na(+) hyperabsorption in murine airways.
Livraghi-Butrico A; Kelly EJ; Wilkinson KJ; Rogers TD; Gilmore RC; Harkema JR; Randell SH; Boucher RC; O'Neal WK; Grubb BR
Am J Physiol Lung Cell Mol Physiol; 2013 Apr; 304(7):L469-80. PubMed ID: 23377346
[TBL] [Abstract][Full Text] [Related]
7. Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?
Strandvik B
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800499
[TBL] [Abstract][Full Text] [Related]
8. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
Shei RJ; Peabody JE; Kaza N; Rowe SM
Curr Opin Pharmacol; 2018 Dec; 43():152-165. PubMed ID: 30340955
[TBL] [Abstract][Full Text] [Related]
9. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
Wagner CA; Ott M; Klingel K; Beck S; Melzig J; Friedrich B; Wild KN; Bröer S; Moschen I; Albers A; Waldegger S; Tümmler B; Egan ME; Geibel JP; Kandolf R; Lang F
Cell Physiol Biochem; 2001; 11(4):209-18. PubMed ID: 11509829
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.
Mutesa L; Azad AK; Verhaeghe C; Segers K; Vanbellinghen JF; Ngendahayo L; Rusingiza EK; Mutwa PR; Rulisa S; Koulischer L; Cassiman JJ; Cuppens H; Bours V
Chest; 2009 May; 135(5):1233-1242. PubMed ID: 19017867
[TBL] [Abstract][Full Text] [Related]
11. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
12. Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease?
Hobbs CA; Da Tan C; Tarran R
J Physiol; 2013 Sep; 591(18):4377-87. PubMed ID: 23878362
[TBL] [Abstract][Full Text] [Related]
13. Correction of defective CFTR/ENaC function and tightness of cystic fibrosis airway epithelium by amniotic mesenchymal stromal (stem) cells.
Carbone A; Castellani S; Favia M; Diana A; Paracchini V; Di Gioia S; Seia M; Casavola V; Colombo C; Conese M
J Cell Mol Med; 2014 Aug; 18(8):1631-43. PubMed ID: 24894806
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease.
Terryah ST; Fellner RC; Ahmad S; Moore PJ; Reidel B; Sesma JI; Kim CS; Garland AL; Scott DW; Sabater JR; Carpenter J; Randell SH; Kesimer M; Abraham WM; Arendshorst WJ; Tarran R
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L192-L205. PubMed ID: 28982737
[TBL] [Abstract][Full Text] [Related]
15. Zinc Deficiency via a Splice Switch in Zinc Importer ZIP2/SLC39A2 Causes Cystic Fibrosis-Associated MUC5AC Hypersecretion in Airway Epithelial Cells.
Kamei S; Fujikawa H; Nohara H; Ueno-Shuto K; Maruta K; Nakashima R; Kawakami T; Matsumoto C; Sakaguchi Y; Ono T; Suico MA; Boucher RC; Gruenert DC; Takeo T; Nakagata N; Li JD; Kai H; Shuto T
EBioMedicine; 2018 Jan; 27():304-316. PubMed ID: 29289532
[TBL] [Abstract][Full Text] [Related]
16. Transgenic hCFTR expression fails to correct β-ENaC mouse lung disease.
Grubb BR; O'Neal WK; Ostrowski LE; Kreda SM; Button B; Boucher RC
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L238-47. PubMed ID: 22003093
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
Mroz MS; Harvey BJ
Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
[TBL] [Abstract][Full Text] [Related]
18. Increased apical Na+ permeability in cystic fibrosis is supported by a quantitative model of epithelial ion transport.
O'Donoghue DL; Dua V; Moss GW; Vergani P
J Physiol; 2013 Aug; 591(15):3681-92. PubMed ID: 23732645
[TBL] [Abstract][Full Text] [Related]
19. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art.
Althaus M
Curr Mol Pharmacol; 2013 Mar; 6(1):3-12. PubMed ID: 23547930
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide targeting of mRNAs encoding ENaC subunits α, β, and γ improves cystic fibrosis-like disease in mice.
Zhao C; Crosby J; Lv T; Bai D; Monia BP; Guo S
J Cyst Fibros; 2019 May; 18(3):334-341. PubMed ID: 30100257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
